A supplier can state that its AI platform is “EU hosted” and still create a material international transfer risk. If support engineers can access production data from outside the EEA, telemetry is routed to a US-based observability service, or a foundation-model provider retains prompts for service improvement, AI data residency is not a procurement checkbox. It is an operating condition that must be defined, evidenced and monitored.
For compliance, legal, risk and security teams, the issue is broader than server location. It concerns where AI-related information is stored, processed, backed up, accessed and made available throughout the system lifecycle. That includes training data, prompts, outputs, user identifiers, risk assessments, model documentation, audit logs and incident records.
What AI data residency actually means
AI data residency is the requirement or organisational commitment to keep specified data within a defined geographic jurisdiction, commonly the UK, the European Economic Area (EEA), or a particular EU Member State. It is often driven by sector rules, public-sector procurement conditions, contractual commitments, data protection risk appetite and customer expectations.
Residency is not identical to data protection compliance. The UK GDPR and EU GDPR regulate personal data processing and restrict certain international transfers, but neither creates a universal requirement that all data must remain in one country. A processing operation may be lawful even where data is transferred outside the UK or EEA, provided the relevant transfer mechanism and safeguards are in place.
That distinction matters. An organisation may accept properly governed transfers for a low-risk internal tool while requiring strict EEA-only processing for customer-facing AI systems, special category data or regulated decision-making. The right control is proportionate to the data, purpose, model capability and operational consequences.
Why AI systems make residency harder to verify
Conventional SaaS due diligence already requires scrutiny of hosting, backups, subprocessors and support access. AI adds processing paths that are easy to overlook and difficult to reconstruct after deployment.
A user prompt may be processed in an EU region, but the provider’s content safety service, vector database, model monitoring function or error-tracing tool may operate elsewhere. Fine-tuning can create a separate data store. Retrieval-augmented generation may pull sensitive records from a connected source, while model logs retain fragments of those records. Even when prompts are not used for model training, they may be retained temporarily for abuse detection, debugging or service quality purposes.
Teams should also distinguish data location from access location. A database held in Frankfurt does not, on its own, prove EEA-only processing. Privileged access from another jurisdiction, offshore support escalation and third-party incident response can each create an access pathway requiring assessment.
For high-risk AI systems under the EU AI Act, these questions have a further governance consequence. Providers and deployers need documentation, logging, risk management and post-market monitoring arrangements that are credible in practice. If evidence is dispersed across cloud portals, procurement folders, model-provider terms and email approvals, demonstrating control to an auditor or regulator becomes slow and unreliable.
The evidence a defensible residency position requires
A residency commitment should be converted into specific, testable requirements. “Data stays in Europe” is too vague for a contract, supplier review or control assessment. Define the scope by data class, geography, processing activity and permitted exception.
For example, a policy may require that production customer data, prompts and outputs are stored and processed in the EEA; backups remain in the EEA; and non-EEA remote access is prohibited unless approved under a documented emergency process. It may permit de-identified aggregate service telemetry outside the EEA, subject to validation that re-identification risk is controlled. The detail will vary, but ambiguity should not.
A credible evidence pack normally includes the following elements:
- a data flow record identifying collection, inference, retrieval, logging, training, backup and deletion locations;
- contractual terms covering processing locations, approved subprocessors, remote access, notice periods and audit rights;
- technical configuration evidence, such as region settings, tenant location, access controls and log retention settings;
- a transfer assessment where personal data may be accessed or processed outside the relevant jurisdiction; and
- periodic supplier assurance evidence, including changes to infrastructure, subprocessor arrangements and model-provider terms.
The key is traceability. Each claim in a supplier questionnaire should map to a contractual clause, technical setting, assurance report or named control owner. A screenshot from a cloud console may support a conclusion, but it does not replace a documented understanding of the end-to-end processing chain.
Treat AI providers and cloud providers separately
Many organisations assess the SaaS provider but fail to assess the AI services embedded beneath it. That is a gap. A governance platform, CRM or customer service tool may use one or more model providers, content moderation services, vector search services and analytics tools. Each can introduce separate residency and transfer implications.
Ask whether the provider can select the inference region, whether data is retained by the model provider, whether zero-retention terms are available, and whether prompts or outputs are used to train any model. Clarify whether the answer applies to every product tier and every feature. Suppliers often make different commitments for enterprise, API and consumer services.
Build residency into AI governance workflows
Residency controls are most effective when they are part of the AI system lifecycle rather than a one-off vendor assessment. Start at registration. Every AI use case should have an accountable owner, defined purpose, data categories, intended users, suppliers and deployment location recorded in the AI inventory.
During classification and risk assessment, assess whether the system processes personal data, special category data, confidential business information or regulated records. Consider both direct processing and indirect exposure through prompts, uploaded documents, integrations and output logs. A low-risk summarisation tool with no personal data may justify a different residency posture from an AI system supporting recruitment, credit decisions or healthcare workflows.
Controls should then be assigned to the system, not left as generic policy statements. Useful control fields include approved hosting region, permitted model providers, data retention period, cross-border access restrictions, transfer mechanism, subprocessor review date and evidence owner. Where an exception is approved, record its rationale, approval authority, compensating controls and expiry date.
This creates a practical route to board reporting. Rather than reporting that “AI suppliers are GDPR compliant”, governance teams can show how many systems meet the required residency standard, which systems have approved exceptions, which supplier attestations are overdue and where residual risk remains. That is decision-useful information.
Map residency to related obligations
AI data residency should not sit in isolation from the wider control environment. It intersects with GDPR accountability, processor due diligence, records of processing activities, data protection impact assessments, access management, incident response and retention controls.
It also supports ISO/IEC 42001 requirements for documented AI management system processes, risk treatment, operational controls and performance evaluation. ISO 42001 does not prescribe a single geography for data, nor does the EU AI Act impose blanket localisation. Both frameworks do, however, increase the value of clear responsibilities, evidence-based risk decisions and repeatable monitoring.
For systems within the EU AI Act’s high-risk regime, data governance and record-keeping obligations make uncontrolled processing pathways especially difficult to defend. Residency is not a substitute for data quality, human oversight, accuracy testing or cybersecurity. It is one part of a broader governance position.
Test the claim after contract signature
Supplier documentation changes. New AI features are released, model providers are replaced, regions are added and support arrangements evolve. A residency assessment conducted at onboarding can become stale long before the annual supplier review.
Set review triggers that reflect AI change. Reassess when a supplier introduces generative AI functionality, enables a new integration, changes its subprocessor list, revises retention terms, moves workloads between regions or proposes using customer data for training. Security incidents and material changes in transfer law should also trigger review.
Technical validation should be proportionate. For a critical system, security teams may inspect configuration, identity logs and data flow architecture. For lower-risk tools, a documented supplier attestation and contractual review may be sufficient. The point is not to create theatre. It is to ensure the assurance method matches the risk and can withstand challenge.
A single system of record prevents this work from reverting to spreadsheet archaeology. Endaxi AIG can bring inventory records, residency controls, supplier evidence, risk decisions, review dates and audit outputs into one accountable workflow. That matters when a DPO, auditor or board member asks a direct question and needs a defensible answer quickly.
The practical standard is simple: do not accept “EU hosted” as a conclusion. Require a defined scope, a mapped data flow, named control owners and current evidence. That is how residency becomes a governed decision rather than a hopeful statement in a supplier brochure.